Whitehawk Therapeutics (WHWK) Retained Earnings (2010 - 2026)
Whitehawk Therapeutics (WHWK) reported Retained Earnings of -$375.4 million for Q1 2026, down 44.59% year-over-year from -$677.4 million in Q1 2025, and down 312933.33% on a QoQ basis from $120000.0 in Q4 2025.
Whitehawk Therapeutics (WHWK) has 17 years of Retained Earnings data on file, last reported at -$375.4 million in Q1 2026.
- Quarterly Retained Earnings fell 44.59% year-over-year to -$375.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$375.4 million (down 44.59% YoY) and the FY2025 annual result came in at $120000.0, up 650.0% from the prior year.
- Retained Earnings slipped to -$375.4 million in Q1 2026 per WHWK's latest filing, from $120000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $120000.0 in Q4 2025 and bottomed at -$375.4 million in Q1 2026.
- The 5-year median for Retained Earnings is -$252.7 million (2023), against an average of -$214.4 million.
- The widest annual swing landed in 2024, when Retained Earnings slumped 685888.64%; it then jumped 650.0% in 2025.
- Tracing WHWK's Retained Earnings over 5 years: stood at -$203.2 million in 2022, then tumbled by 32.36% to -$269.0 million in 2023, then soared by 100.01% to $16000.0 in 2024, then jumped by 650.0% to $120000.0 in 2025, then slumped by 312933.33% to -$375.4 million in 2026.
- Per Business Quant, the three latest WHWK Retained Earnings figures stand at -$375.4 million (Q1 2026), $120000.0 (Q4 2025), and -$330.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - | -375.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -375.40 Mn |
| Dec 31, 2025 | 120,000.00 |
| Sep 30, 2025 | -330.00 Mn |
| Jun 30, 2025 | -312.30 Mn |
| Mar 31, 2025 | -259.64 Mn |
| Dec 31, 2024 | 16,000.00 |
| Sep 30, 2024 | -314.40 Mn |
| Jun 30, 2024 | -301.84 Mn |
| Mar 31, 2024 | -287.30 Mn |
| Dec 31, 2023 | -268.96 Mn |
| Sep 30, 2023 | -252.70 Mn |
| Jun 30, 2023 | -44,000.00 |
| Mar 31, 2023 | -218.40 Mn |
| Dec 31, 2022 | -203.20 Mn |
| Sep 30, 2022 | -189.29 Mn |
| Jun 30, 2022 | -174.80 Mn |
| Mar 31, 2022 | -156.54 Mn |
| Dec 31, 2021 | -142.69 Mn |
| Sep 30, 2021 | -126.70 Mn |
| Jun 30, 2021 | -155.40 Mn |
| Mar 31, 2021 | -150.99 Mn |
| Dec 31, 2020 | -32.60 Mn |
| Sep 30, 2020 | -141.83 Mn |
| Jun 30, 2020 | -136.88 Mn |
| Mar 31, 2020 | -146.15 Mn |
| Dec 31, 2019 | -142.24 Mn |
| Sep 30, 2019 | -137.79 Mn |
| Jun 30, 2019 | -133.14 Mn |
| Mar 31, 2019 | -127.46 Mn |
| Dec 31, 2018 | -118.96 Mn |
| Sep 30, 2018 | -110.44 Mn |
| Jun 30, 2018 | -121.98 Mn |
| Mar 31, 2018 | -115.99 Mn |
| Dec 31, 2017 | -108.56 Mn |
| Sep 30, 2017 | -102.33 Mn |
| Jun 30, 2017 | -97.68 Mn |
| Mar 31, 2017 | -92.16 Mn |
| Dec 31, 2016 | -86.22 Mn |
| Sep 30, 2016 | -257,257.00 |
| Jun 30, 2016 | -250,483.00 |
| Mar 31, 2016 | -242,837.00 |
| Dec 31, 2015 | -236,481.00 |
| Sep 30, 2015 | -224,649.00 |
| Jun 30, 2015 | -218,128.00 |
| Mar 31, 2015 | -210,856.00 |
| Dec 31, 2014 | -205,041.00 |
| Sep 30, 2014 | 193,388.00 |
| Jun 30, 2014 | 186,960.00 |
| Mar 31, 2014 | 180,008.00 |
| Dec 31, 2013 | 174,242.00 |
| Sep 30, 2013 | 164,492.00 |
| Jun 30, 2013 | 158,353.00 |
| Mar 31, 2013 | 151,604.00 |
| Dec 31, 2012 | 145,541.00 |
| Sep 30, 2012 | 135,879.00 |
| Jun 30, 2012 | 129,841.00 |
| Mar 31, 2012 | 123,538.00 |
| Dec 31, 2011 | 118,176.00 |
| Sep 30, 2011 | 109,242.00 |
| Jun 30, 2011 | 102,905.00 |
| Dec 31, 2010 | 90,991.00 |